NASDAQ:VERU
Veru Stock News
$1.27
+0.0600 (+4.96%)
At Close: Apr 26, 2024
Got $5,000? These 2 Stocks Are Crushing the Market This Year
10:45am, Wednesday, 10'th Aug 2022
Can they continue outperforming the S&P?
Perrigo (PRGO) Lags Q2 Earnings Estimates
11:45am, Tuesday, 09'th Aug 2022 Zacks Investment Research
Perrigo (PRGO) delivered earnings and revenue surprises of -2.27% and 5.36%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
Envista (NVST) Q2 Earnings Top Estimates
11:45pm, Wednesday, 03'rd Aug 2022 Zacks Investment Research
Envista (NVST) delivered earnings and revenue surprises of 4.35% and 1.79%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
Veru Inc. (VERU) Stock Sinks As Market Gains: What You Should Know
10:15pm, Friday, 29'th Jul 2022 Zacks Investment Research
In the latest trading session, Veru Inc. (VERU) closed at $12.10, marking a -0.9% move from the previous day.
European Medicines Agency’s Emergency Task Force Has Initiated the Review of Veru's Sabizabulin Treatment for Hospitalized COVID-19 Patients for Emergency Use in European Union Countries
03:00pm, Wednesday, 27'th Jul 2022 GlobeNewswire Inc.
MIAMI, July 27, 2022 (GLOBE NEWSWIRE) -- Veru Inc. (NASDAQ: VERU), a biopharmaceutical company focused on developing novel medicines for COVID-19 and other viral and ARDS-related diseases and for th
UK’s Medicines and Healthcare Products Regulatory Agency (MHRA) Supports Expedited Review of Marketing Authorization Application for Sabizabulin Treatment in Hospitalized COVID-19 Patients
11:30am, Monday, 25'th Jul 2022 GlobeNewswire Inc.
MIAMI, July 25, 2022 (GLOBE NEWSWIRE) -- Veru Inc. (NASDAQ: VERU), a biopharmaceutical company focused on developing novel medicines for COVID-19 and other viral and ARDS-related diseases and for th
Beyond Meat, Canoo, Veru And More: 12 Short Squeeze Candidates To Watch
02:28pm, Wednesday, 20'th Jul 2022 Benzinga
One of the most powerful tradable market events is a short squeeze, so traders are always on the lookout for the next short squeeze candidate. S3 Partners analyst Ihor Dusaniwsky has just released a l
Biotech Stock Roundup: ICPT's Study Data, NVAX Vaccine Gets EUA, VERU Up on Data
04:13pm, Thursday, 14'th Jul 2022 Zacks Investment Research
Regulatory and other updates from Intercept (ICPT) and VERU are a few key highlights from the biotech sector during the past week.
Bear Market Winners: 3 Healthcare Stocks That Have Soared More Than 30% This Year
02:45pm, Thursday, 14'th Jul 2022 The Motley Fool
Have these scorching-hot stocks peaked, or could there still be more gains ahead for investors who buy today?
Why Veru Stock Jumped Today
03:15pm, Wednesday, 13'th Jul 2022 The Motley Fool
The company is generously paying a few new hires.
Veru: The Signs Seem To Point To An EUA For Sabizabulin
12:04pm, Wednesday, 13'th Jul 2022
Veru ought to find out very soon whether its lead asset, Sabizabulin, has been awarded an Emergency Use Authorization to treat hospitalized COVID patients. The company's share price leapt >$20 when it
Why Veru Stock Jumped Today
11:15am, Wednesday, 13'th Jul 2022
The company is generously paying a few new hires.
Veru Inc. (VERU) Dips More Than Broader Markets: What You Should Know
10:15pm, Tuesday, 12'th Jul 2022 Zacks Investment Research
In the latest trading session, Veru Inc. (VERU) closed at $15, marking a -1.96% move from the previous day.
Veru Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
08:30pm, Tuesday, 12'th Jul 2022 GlobeNewswire Inc.
MIAMI, July 12, 2022 (GLOBE NEWSWIRE) -- Veru Inc. (NASDAQ: VERU), a biopharmaceutical company focused on developing novel medicines for COVID-19 and other viral and ARDS-related diseases and for th
Alibaba, Zoom Video And 76 Biggest Movers From Yesterday
09:35am, Tuesday, 12'th Jul 2022 Benzinga
Gainers
Kaspien Holdings Inc. (NASDAQ: KSPN) shares climbed 161.9% to close at $6.81 on Monday on heavy volume amid mention of the stock on social media.
Pliant Therapeutics, Inc. (NASDAQ: PLRX) sha
